Founded in 2014, Mirxes is a leading biotechnology company focused on saving lives and improving health economics and outcomes, through RNA-powered disease early detection and precision genomic tests. Mirxes Genomics is a Singapore-based laboratory that provides white-glove genomic services for academic, clinical and biopharmaceutical research. With a dedicated team of highly experienced scientists, Mirxes Genomics specializes in pre-project consultation, large cohort studies and efficient bioinformatics analysis. As the world’s first Certified Service Provider of STOmics, Mirxes Genomics is committed to providing excellent customer experience and advancing scientific discoveries using the world-leading spatial technology.